Viewing Study NCT06855095

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:16 PM
Ignite Modification Date: 2026-05-13 @ 3:56 PM
Study NCT ID: NCT06855095
Status: RECRUITING
Last Update Posted: 2025-03-03
First Post: 2023-10-25
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial
Sponsor: The Netherlands Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroendocrine Tumors View
None Neuroendocrine Tumor Grade 1 View
None Neuroendocrine Tumor Grade 2 View
None Neuroendocrine Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Peptide Receptor Radionuclide Therapy View
None PRRT View
None Lutetium View
None DOTATATE View